<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102-biomedicines-08-00109">
 <label>102.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deng</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zeng</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study</article-title>
  <source>J. Infect.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.002</pub-id>
 </element-citation>
</ref>
